Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ala”

271 pharma patents match "ala" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 2 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "ala" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “ala” · 30,257 patents in full index Clear search

  1. US 12091388

    Solid state forms of Reproxalap

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted

  2. WO 2024175803

    COMPOSÉS POUR LE TRAITEMENT DE MALADIES MYÉLOÏDES AVEC DES ANOMALIES CHROMOSOMIQUES

    AB SCIENCE [FR] · Granted Aug 29, 2024 · Expires Aug 24, 2044

    granted

  3. US 12059418

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted

  4. US 12054607

    Tough, healable composites displaying stress relaxation at the resin-filler interface

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted

  5. US 11918633

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted

  6. US 11919915

    Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations

    Agios Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted

  7. WO 2024039256

    RÉGIMES THÉRAPEUTIQUES POUR LA MALADIE DE PARKINSON

    BIAL PORTELA & CA SA [PT] · Granted Feb 22, 2024 · Expires Feb 17, 2044

    granted

  8. US 11903936

    Anti-malarial agents

    The Board of Regents of the University of Texas System · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted

  9. IT 202200013882

    PRODOTTO DI FERMENTAZIONE PER IL TRATTAMENTO DI MALATTIE INFIAMMATORIE.

    ALFASIGMA SPA [IT] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted

  10. US 11780805

    Carbamoyl phenylalaninol compounds and uses thereof

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11771748

    Methods for treating tumor-induced osteomalacia

    Ultragenyx Pharmaceutical Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  12. US 11753408

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  13. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  14. EP 4210672

    HYALURONSÄURE ODER SALZ DAVON ZUR INHALATION ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN UND INHALATORVORRICHTUNG DAMIT

    ALFASIGMA SPA [IT] · Granted Jul 19, 2023 · Expires Jul 14, 2043

    granted

  15. CA 3235096

    METHODES DE TRAITEMENT DE L'ANEMIE CAUSEE PAR UNE MALADIE RENALE

    DISC MEDICINE INC [US] · Granted May 25, 2023 · Expires May 20, 2043

    granted

  16. IT 202100026282

    Surnatante fermentato e composizioni postbiotiche utili nella prevenzione e nel trattamento di malattie cardiovascolari

    ALFASIGMA SPA [IT] · Granted Apr 13, 2023 · Expires Apr 8, 2043

    granted

  17. US 11510998

    Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin C type, and deficiency of MMACHC

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  18. US 11505790

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  19. WO 2022234069

    NOUVEAUX DÉRIVÉS DE 2-AMINOOXAZOLE ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES INFECTIEUSES

    AB SCIENCE [FR] · Granted Nov 10, 2022 · Expires Nov 5, 2042

    granted

  20. US 11446365

    Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  21. US 11446360

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Amphastar Pharmaceuticals, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  22. US 11413264

    Carbamoyl phenylalaninol analogs and uses thereof

    Jazz Pharmaceuticals Ireland Limited · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  23. US 11407997

    Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders

    CRISPR THERAPEUTICS AG · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  24. WO 2022158991

    TRAITEMENT DE LA DOULEUR ASSOCIÉE À LA MALADIE DE PARKINSON AVEC DE L'OPICAPONE EN COMBINAISON AVEC LA LÉVODOPA

    BIAL PORTELA & CA SA [PT] · Granted Jul 28, 2022 · Expires Jul 23, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.